These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9328628)

  • 1. Central serotonergic system and mechanism of anxiolytic action.
    Plaznik A; Stefański R; Jessa M; Nazar M; Bidziński A
    Acta Physiol Hung; 1996; 84(4):449-51. PubMed ID: 9328628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limbic mechanisms of anxiolytics acting on 5-HT receptors.
    Płaźnik A; Kostowski W; Stefański R
    Pol J Pharmacol; 1994; 46(5):473-7. PubMed ID: 7894537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.
    Stefański R; Pałejko W; Bidziński A; Kostowski W; Płaźnik A
    Neuropharmacology; 1993 Oct; 32(10):987-93. PubMed ID: 7905195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists.
    Stefański R; Pałejko W; Bidziński A; Kostowski W; Płaźnik A
    Neuropharmacology; 1993 Oct; 32(10):977-85. PubMed ID: 7905194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze.
    Clénet F; Hascoët M; Fillion G; Galons H; Bourin M
    Behav Brain Res; 2005 Mar; 158(2):339-48. PubMed ID: 15698901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation.
    Müller CP; Carey RJ; De Souza Silva MA; Jocham G; Huston JP
    Synapse; 2002 Aug; 45(2):67-77. PubMed ID: 12112399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
    J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
    Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
    J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two animal models of anxiety--different sensitivity for anxiolytic action of GABAA receptor complex ligands.
    Nazar M; Płaznik A; Jessa M
    Acta Physiol Hung; 1996; 84(4):437-9. PubMed ID: 9328625
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion.
    Pratt WE; Blackstone K; Connolly ME; Skelly MJ
    Behav Neurosci; 2009 Oct; 123(5):1046-57. PubMed ID: 19824770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
    Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
    Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
    Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
    Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
    Wesołowska A; Nikiforuk A; Stachowicz K
    Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanisms of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives, serotonin agonists].
    Talalaenko AN; Kharin NA
    Eksp Klin Farmakol; 1993; 56(2):11-3. PubMed ID: 8102289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
    Wesołowska A; Nikiforuk A; Stachowicz K
    Eur J Pharmacol; 2006 Dec; 553(1-3):185-90. PubMed ID: 17097082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.